Implantable enzyme capsules for cancer chemotherapy from bakers’ yeast cytosine deaminase immobilized on epoxy-acrylic resin and urethane prepolymer

Publisher Website
Google Scholar
Abstract
For trial use in the local chemotherapy of cancer by a combination of cytosine deaminase (EC 3.5.4.1) and 5-fluorocytosine (J. Biotechnol., (1985),2, 13–21), 40 U of partially purified cytosine deaminase was obtained from 500 g of commercial compressed bakers’ yeast. The enzyme, which is unstable, was immobilized to stabilize it by the use of commercial epoxyacrylic beads (Eupergit C). The immobilized enzyme was made into enzyme capsules with cellulose tubing for dialysis to encapsulate it or urethane polymer to entrap it, which materials are biocompatible. The activity of the intact cellulose capsules thus made was 0.4% that of the immobilized enzyme inside. The enzyme capsules also were stable. Ten days after the cellulose capsules were implanted in rats, 25% of the starting activity remained. When the polyurethane capsules were tested in vitro for 9 mo for thermostability at 37°C, the activity decreased rapidly (with a half-life of 28 d) during the first 4 mo, and then slowly (half-life, about 100 d) during the next 5 mo. A calculation to transform the biphasic decline into a sum of the exponential decline of two components of enzymic activities with different strengths and half-lives showed that the larger half-life was 5 mo.